Developmental neurotoxicity (DNT): A call for implementation of new approach methodologies for regulatory purposes: Summary of the 5th International Conference on DNT Testing.

IF 5.8 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Ivana Celardo, Michael Aschner, Randolph S Ashton, Kelly E Carstens, Andrea Cediel-Ulloa, Eike Cöllen, Kevin M Crofton, Susan J Debad, Nadine Dreser, Suzanne Fitzpatrick, Ellen Fritsche, Sebastian Gutsfeld, Barry Hardy, Thomas Hartung, Ellen Hessel, Harm Heusinkveld, Helena T Hogberg, Jui-Hua Hsieh, Yasunari Kanda, Gavin T Knight, Thomas Knudsen, Katharina Koch, Eliska Kuchovska, Iris Mangas, M Sue Marty, Stephanie Melching-Kollmuss, Iris Müller, Patrick Müller, Oddvar Myhre, Martin Paparella, Emily Pitzer, Anna Bal-Price, Magdalini Sachana, Kevin Schlüppmann, Timothy J Shafer, Jasmin Schäfer, Lena Smirnova, Tamara Tal, Yaroslav Tanaskov, Silvia Tangianu, Giuseppe Testa, Anna-Katharina Ückert, Maurice Whelan, Marcel Leist
{"title":"Developmental neurotoxicity (DNT): A call for implementation of new approach methodologies for regulatory purposes: Summary of the 5th International Conference on DNT Testing.","authors":"Ivana Celardo, Michael Aschner, Randolph S Ashton, Kelly E Carstens, Andrea Cediel-Ulloa, Eike Cöllen, Kevin M Crofton, Susan J Debad, Nadine Dreser, Suzanne Fitzpatrick, Ellen Fritsche, Sebastian Gutsfeld, Barry Hardy, Thomas Hartung, Ellen Hessel, Harm Heusinkveld, Helena T Hogberg, Jui-Hua Hsieh, Yasunari Kanda, Gavin T Knight, Thomas Knudsen, Katharina Koch, Eliska Kuchovska, Iris Mangas, M Sue Marty, Stephanie Melching-Kollmuss, Iris Müller, Patrick Müller, Oddvar Myhre, Martin Paparella, Emily Pitzer, Anna Bal-Price, Magdalini Sachana, Kevin Schlüppmann, Timothy J Shafer, Jasmin Schäfer, Lena Smirnova, Tamara Tal, Yaroslav Tanaskov, Silvia Tangianu, Giuseppe Testa, Anna-Katharina Ückert, Maurice Whelan, Marcel Leist","doi":"10.14573/altex.2503191","DOIUrl":null,"url":null,"abstract":"<p><p>The 5th International Conference on Developmental Neurotoxicity (DNT) Testing (DNT5) took place in April 2024 in Konstanz, Germany, organized by CAAT-Europe, the University of Konstanz, and scientists from the US EPA, SCAHT, and CAAT at Johns Hopkins University Bloomberg School of Public Health. The conference convened experts from regulatory agencies, industry, and academia to explore the latest advancements in DNT testing and the integration of animal-free new approach methodologies (NAMs) into next-generation risk assessment (NGRA). The key topic was the appli-cation and further development of the recently established DNT in vitro test battery (DNT-IVB). To support this, OECD held a satellite meeting to discuss necessary next steps for further implementation of the DNT-IVB in regulatory contexts. Validation of new DNT test methods and use of their data for in-vitro-to-in-vivo extrapolations in physiologically based kinetic models were also important themes of the main meeting. In this context, the question was raised when a comprehensive biological and chemical coverage by the DNT-IVB would be reached. A need for additional testing data was recognized. Context-specific validation approaches for the entire DNT-IVB and the potential for intelligent combinations of assays to enhance the predictive power of the test battery were also addressed. Many presentations demonstrated the field's embrace of novel developments, including the use of multi-endpoint embryonic zebrafish tests, the development of artificial intelligence-driven computational approaches, and the establishment of complex, electrically active brain organoids and other self-organizing structures. Through its highly interactive format, DNT5 promoted extensive collaborative efforts in advancing the field toward more human-relevant, scientifically reliable, and ethical toxicological assessments.</p>","PeriodicalId":51231,"journal":{"name":"Altex-Alternatives To Animal Experimentation","volume":"42 2","pages":"323-349"},"PeriodicalIF":5.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Altex-Alternatives To Animal Experimentation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14573/altex.2503191","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

The 5th International Conference on Developmental Neurotoxicity (DNT) Testing (DNT5) took place in April 2024 in Konstanz, Germany, organized by CAAT-Europe, the University of Konstanz, and scientists from the US EPA, SCAHT, and CAAT at Johns Hopkins University Bloomberg School of Public Health. The conference convened experts from regulatory agencies, industry, and academia to explore the latest advancements in DNT testing and the integration of animal-free new approach methodologies (NAMs) into next-generation risk assessment (NGRA). The key topic was the appli-cation and further development of the recently established DNT in vitro test battery (DNT-IVB). To support this, OECD held a satellite meeting to discuss necessary next steps for further implementation of the DNT-IVB in regulatory contexts. Validation of new DNT test methods and use of their data for in-vitro-to-in-vivo extrapolations in physiologically based kinetic models were also important themes of the main meeting. In this context, the question was raised when a comprehensive biological and chemical coverage by the DNT-IVB would be reached. A need for additional testing data was recognized. Context-specific validation approaches for the entire DNT-IVB and the potential for intelligent combinations of assays to enhance the predictive power of the test battery were also addressed. Many presentations demonstrated the field's embrace of novel developments, including the use of multi-endpoint embryonic zebrafish tests, the development of artificial intelligence-driven computational approaches, and the establishment of complex, electrically active brain organoids and other self-organizing structures. Through its highly interactive format, DNT5 promoted extensive collaborative efforts in advancing the field toward more human-relevant, scientifically reliable, and ethical toxicological assessments.

发育性神经毒性(DNT):呼吁为监管目的实施新的方法方法:第五届DNT测试国际会议摘要
第五届发育性神经毒性(DNT)测试国际会议(DNT5)于2024年4月在德国康斯坦茨举行,由CAAT- europe、康斯坦茨大学以及来自美国环保署、SCAHT和约翰霍普金斯大学彭博公共卫生学院CAAT的科学家组织。会议召集了来自监管机构、工业界和学术界的专家,探讨DNT测试的最新进展,以及将无动物新方法方法(NAMs)整合到下一代风险评估(NGRA)中。重点讨论了最近建立的DNT体外测试电池(DNT- ivb)的应用和进一步发展。为了支持这一点,经合组织举行了一次卫星会议,讨论在监管背景下进一步实施DNT-IVB的必要后续步骤。新的DNT测试方法的验证以及将其数据用于基于生理学的动力学模型的体外到体内外推也是主要会议的重要主题。在这方面,有人提出了一个问题,即什么时候才能达到生物和化学方面的全面覆盖。认识到需要额外的测试数据。还讨论了整个DNT-IVB的特定环境验证方法以及智能分析组合的潜力,以提高测试电池的预测能力。许多演讲展示了该领域对新发展的拥抱,包括使用多端点胚胎斑马鱼测试,开发人工智能驱动的计算方法,以及建立复杂的、电活动的脑类器官和其他自组织结构。通过其高度互动的形式,DNT5促进了广泛的合作努力,推动该领域朝着更加与人类相关、科学可靠和符合伦理的毒理学评估方向发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Altex-Alternatives To Animal Experimentation
Altex-Alternatives To Animal Experimentation MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
7.70
自引率
8.90%
发文量
89
审稿时长
2 months
期刊介绍: ALTEX publishes original articles, short communications, reviews, as well as news and comments and meeting reports. Manuscripts submitted to ALTEX are evaluated by two expert reviewers. The evaluation takes into account the scientific merit of a manuscript and its contribution to animal welfare and the 3R principle.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信